JPS5524150A - Anti-malignant-tumor agent - Google Patents

Anti-malignant-tumor agent

Info

Publication number
JPS5524150A
JPS5524150A JP9770378A JP9770378A JPS5524150A JP S5524150 A JPS5524150 A JP S5524150A JP 9770378 A JP9770378 A JP 9770378A JP 9770378 A JP9770378 A JP 9770378A JP S5524150 A JPS5524150 A JP S5524150A
Authority
JP
Japan
Prior art keywords
arabinofuranosylcytosine
cytidine
tumor agent
malignant
mole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP9770378A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6231690B2 (enrdf_load_html_response
Inventor
Setsuo Fujii
Norio Saimi
Setsuo Takeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to JP9770378A priority Critical patent/JPS5524150A/ja
Publication of JPS5524150A publication Critical patent/JPS5524150A/ja
Publication of JPS6231690B2 publication Critical patent/JPS6231690B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP9770378A 1978-08-09 1978-08-09 Anti-malignant-tumor agent Granted JPS5524150A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9770378A JPS5524150A (en) 1978-08-09 1978-08-09 Anti-malignant-tumor agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9770378A JPS5524150A (en) 1978-08-09 1978-08-09 Anti-malignant-tumor agent

Publications (2)

Publication Number Publication Date
JPS5524150A true JPS5524150A (en) 1980-02-21
JPS6231690B2 JPS6231690B2 (enrdf_load_html_response) 1987-07-09

Family

ID=14199276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9770378A Granted JPS5524150A (en) 1978-08-09 1978-08-09 Anti-malignant-tumor agent

Country Status (1)

Country Link
JP (1) JPS5524150A (enrdf_load_html_response)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470838A (en) * 1987-10-28 1995-11-28 Pro-Neuron, Inc. Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
US5583117A (en) * 1987-10-28 1996-12-10 Pro-Neuron, Inc. Acylated uridine and cytidine for elevating tissue uridine and cytidine

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470838A (en) * 1987-10-28 1995-11-28 Pro-Neuron, Inc. Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
US5583117A (en) * 1987-10-28 1996-12-10 Pro-Neuron, Inc. Acylated uridine and cytidine for elevating tissue uridine and cytidine
US6258795B1 (en) 1987-10-28 2001-07-10 Pro-Neuron, Inc. Acylated uridine and cytidine and uses thereof
US6274563B1 (en) 1987-10-28 2001-08-14 Pro-Neuron, Inc. Acylated uridine and cytidine and uses thereof
US6316426B1 (en) 1987-10-28 2001-11-13 Pro-Neuron, Inc. Acylated uridine and cytidine and uses thereof

Also Published As

Publication number Publication date
JPS6231690B2 (enrdf_load_html_response) 1987-07-09

Similar Documents

Publication Publication Date Title
JPS53113008A (en) Constant rate releasing preparation
IE45390L (en) Anti-caries composition
ATE450265T1 (de) Pharmazeutische mischung zur behandlung von krebs,die dioxolan nukleosidanalogen enthält
IL140848A (en) Pharmaceutical compositions containing phenylacetylglutamine, phenylacetylisoglutamine and/or phenylacetate
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
IT1247945B (it) Agente avente attivita' batteriostatica e battericida
GB2192134A (en) Transdermal delivery of drugs
PT78019B (en) Process for preparing rebeccamycin and of pharmaceutical compositions containing the same
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
ATE141802T1 (de) Illudin-analoge, verwendet als antitumormittel
JPS6434909A (en) Cosmetic
ATE96662T1 (de) Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen.
JPS5524150A (en) Anti-malignant-tumor agent
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
DE59005128D1 (de) t-PA pro STABILISIERUNG.
JPS5299217A (en) Vermin attractants
JPS53148518A (en) Stabilized prostaglandin e composition and its preparation
JPS56128711A (en) Glucose-electrolyte preparation for high-calorie transfusion
JPS57144217A (en) Antitumor agent
JPS5533409A (en) Carcinostatic agent
JPS53144939A (en) Adhesive for hard tissue of living body
JPS56164120A (en) Antitumor agent
EP0353910A3 (en) Human interferon-gamma, process for preparing said human interferon-gamma, and its use
JPS56147704A (en) Dermatological composition
JPS5359095A (en) Preparation of 7-aminocephem cpds.